English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Key Clinical Message  Autologous formalin‐fixed tumor vaccine ( AFTV ) suppressed re‐recurrence for more than 32 months of multiple‐recurrent hepatocellular carcinoma based on hepatitis C virus‐induced liver cirrhosis in a case with previous recurrence interval, 51‐, 28‐, 12‐, and 4‐months. We detected glypican‐3‐specific cytotoxic T lymphocytes in the peripheral blood at 12 months after  AFTV .

clinical case reports

Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin‐fixed tumor vaccine, with special reference to glypican‐3